CH211ZZ
Tomographic (Tomo) Nuclear Medicine Imaging Breast, Left to None with None, Technetium 99m (Tc-99m) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | H Skin, Subcutaneous Tissue and Breast |
| Operation | 2 Tomographic (Tomo) Nuclear Medicine Imaging |
| Body Part | 1 Breast, Left |
| Approach | 1 Technetium 99m (Tc-99m) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the capture of radioactive emissions
Procedure Overview
This family covers nuclear medicine scans that create three-dimensional images of the skin, subcutaneous tissue, or breast after a small amount of radioactive tracer is introduced into the body. The tracer collects in the tissue of interest, and a rotating camera captures its emissions from many angles so a computer can reconstruct cross-sectional and volumetric images, similar in concept to a CT scan but built from radioactivity rather than X-rays. The most common clinical use is lymphoscintigraphy to map the sentinel lymph node before breast cancer surgery, letting the surgeon remove only the nodes most likely to contain spreading cancer cells rather than a larger, more invasive node dissection.
Because the tomographic technique resolves depth and layering, it is chosen over a flat, single-plane scan when the surgical team needs to know not just whether a node lit up but exactly where it sits relative to skin landmarks and deeper structures. Patients typically receive the tracer by injection near the tumor site hours before imaging, and the scan itself is painless, though some may find lying still for the acquisition tedious.
Anatomy & Axis Detail
Breast, Left
Tomographic nuclear medicine imaging of the left breast produces sectional images through reconstruction of multiple projection angles, giving three-dimensional localization of tracer uptake that is particularly useful when nodal drainage patterns are atypical or when planar imaging leaves the anatomic relationship between a node and the chest wall unclear. Given the left breast's anatomic proximity to the heart, tomographic reconstruction can help separate cardiac blood pool activity from true nodal or lesional uptake more reliably than a flat projection image. This modality is generally reserved for cases requiring finer spatial detail than planar imaging provides. Documentation should specify that tomographic, not planar, technique was used and that findings were confined to the left breast.
Radionuclide: Technetium 99m (Tc-99m)
Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.
Coding & Documentation
A coder should confirm the operative or radiology report explicitly documents a three-dimensional or SPECT-style acquisition rather than a single static image set, since planar and tomographic studies carry different root operation values even when the same tracer and body area are involved. The physiological system value for breast versus generalized skin/subcutaneous tissue also needs to match the anatomy actually imaged, not just the underlying diagnosis being worked up. A frequent error is coding a combined SPECT/CT lymphoscintigraphy study using only the nuclear medicine tables while ignoring documentation that a separate CT component was fused in, which may need its own code depending on payer and facility conventions. Another recurring mix-up is selecting the qualifier for the radionuclide or radiopharmaceutical class without verifying it against the actual agent named in the report.